Search Results
CELL REPLACEMENT THERAPY: A PRIMER
As the first stem cell therapies have gone into clinical trial to test if they are safe and effective, we have put together a primer to help our readers understand them, and...
READ MOREWHAT ARVO 2026 TOLD US ABOUT THE FUTURE OF VISION RESEARCH
Each year, researchers, clinicians, companies, and organizations from around the world gather at the Association for Research in Vision and Ophthalmology (ARVO) meeting to share the latest advances in eye and vision...
READ MORESCIENCE INTO SIGHT
Age-related macular degeneration (AMD) is the leading cause of vision loss in people aged 55+, affecting 2.5 million Canadians. Learn about AMD.
READ MOREWOMEN ADVANCING VISION HEALTH RESEARCH
Leading Discovery, Driving Change March 8 is International Women’s Day and we wanted to take the opportunity to highlight some woman in vision health research who are shaping the future of how...
READ MOREAMD RESEARCH UPDATE: WHAT’S NEW, WHAT’S COMING, AND WHAT MATTERS MOST FOR CANADIANS
Age-related macular degeneration (AMD) remains a leading cause of vision loss for older Canadians, but the research landscape is changing. While we don’t yet have a cure, new treatments and technologies are...
READ MORETOP 10 HIGHLIGHTS OF 2025
A year of strategy, science, and community: accelerating vision health across Canada In 2025, Fighting Blindness Canada (FBC) advanced a bold agenda: strengthening research leadership, expanding education and community programs, and translating...
READ MOREJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.